Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 39% ± 22% | |
lung | 10 studies | 25% ± 8% | |
eye | 8 studies | 28% ± 14% | |
peripheral blood | 6 studies | 25% ± 5% | |
heart | 4 studies | 26% ± 5% | |
liver | 4 studies | 35% ± 17% | |
intestine | 4 studies | 21% ± 5% | |
adipose | 3 studies | 37% ± 10% | |
kidney | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1826.14 | 1445 / 1445 | 100% | 24.85 | 183 / 183 |
ovary | 100% | 2391.34 | 180 / 180 | 100% | 19.62 | 430 / 430 |
brain | 100% | 1638.79 | 2638 / 2642 | 100% | 22.89 | 705 / 705 |
lung | 100% | 1904.38 | 576 / 578 | 100% | 20.57 | 1155 / 1155 |
prostate | 100% | 1964.58 | 245 / 245 | 100% | 19.05 | 500 / 502 |
breast | 100% | 2447.40 | 459 / 459 | 99% | 26.59 | 1109 / 1118 |
thymus | 100% | 2285.81 | 653 / 653 | 99% | 18.74 | 600 / 605 |
uterus | 100% | 2746.16 | 170 / 170 | 99% | 22.40 | 454 / 459 |
bladder | 100% | 2252.57 | 21 / 21 | 98% | 17.05 | 496 / 504 |
stomach | 100% | 1443.05 | 359 / 359 | 98% | 18.74 | 280 / 286 |
intestine | 100% | 2266.24 | 966 / 966 | 98% | 17.12 | 514 / 527 |
pancreas | 100% | 954.31 | 327 / 328 | 98% | 15.25 | 174 / 178 |
kidney | 100% | 1210.46 | 89 / 89 | 94% | 13.82 | 850 / 901 |
skin | 100% | 2023.27 | 1808 / 1809 | 90% | 19.12 | 426 / 472 |
liver | 100% | 1272.12 | 226 / 226 | 89% | 9.76 | 362 / 406 |
adrenal gland | 100% | 1382.47 | 258 / 258 | 87% | 7.41 | 200 / 230 |
blood vessel | 100% | 2084.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1828.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1819.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.45 | 1 / 1 |
adipose | 100% | 2282.26 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 1135.70 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 14.08 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 54% | 5.44 | 43 / 80 |
peripheral blood | 52% | 787.37 | 486 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF644 |
Protein name | ZNF644 protein Alternative protein ZNF644 Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2) |
Synonyms | KIAA1221 ZEP2 |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | Q569I6 ENST00000347275.9 [Q9H582-3] Q9H582 ENST00000361321.5 [Q9H582-3] L0R5F4 ENST00000370440.5 [Q9H582-1] A7E234 Q8NEI6 ENST00000337393.10 [Q9H582-1] |